Patient Recruitment/Retention Featured Articles

1. The Promise Of MRD-Guided CAR-T Treatment 9/3/2026

   Minimal residual disease markers can reveal relapse before clinical signs appear, when off-the-shelf cell therapy may have its greatest advantage.

2. The Pharmacy Benefit No One Is Managing: Clinical Research As A Care Option 8/28/2026

   Pharmacies could make trials more accessible — if they preserve patient trust while research partners handle the operational burden.

3. It Is Time To Require Human-Relevant Efficacy Evidence Before First-In-Human Trials 8/26/2026

   Why, when human-relevant evidence of likely efficacy can be generated before a trial begins, is it not evaluated before patients are exposed?

4. Sustainable Patient Engagement: Your Enrollment And Representation Depend On It 8/21/2026

   Early and ongoing patient engagement is a crucial component to staving off recruitment trouble and securing proper patient representation. Boehringer Ingelheim's Karen Correa, Ph.D., explains how.

5. 'How Do You Feel?': Designing A Cardiac Trial With A Patient-Reported Primary Endpoint 8/21/2026

   Imbria Pharmaceuticals' Albert Kim, MD, Ph.D., shares why PROs are the point of the company's FORTITUDE-HCM trial for patients with non-obstructive hypertrophic cardiomyopathy.

6. The Art And Skill Of Caring For Terminally Ill Patients In Clinical Research And Beyond 8/14/2026

   When designing and conducting trials for terminally ill patients, Kamila Novak reminds researchers to act and speak with respect, warmth, and thoughtfulness.

7. Early Patient Education And Community Outreach Are Advancing Representation In Clinical Trials 7/16/2026

   Merck Executive Director, Clinical Trial Patient Representation, Adrelia Allen argues that patient awareness, access, early information, and trust shape are the pillars of patient representation in clinical trials.

8. Digital Twins Enhance Disease Progression Measurements In FSHD 7/14/2026

   Digital twins can transform trial design by making data more robust and alleviating patient burden. In this interview, Epicrispr CEO Amber Salzman, Ph.D., shares how the company's using it to reliably predict muscle volume change in their trial for a FSHD gene therapy. 

9. How One Researcher's Personal Study Experience Is Helping Him Better Serve Patients 7/6/2026

   Regeneron Executive Director in Clinical Sciences Kaniel Cassady, Ph.D., reflects on how his industry experience shaped his expectations, questions, and interactions as a patient in a clinical trial and how his patient experience is reshaping his clinical work going forward.

10. Social Media Is Replete With Patient RWD, But How Can Researchers Best Use It? 7/1/2026

    Pistoia Alliance's Thierry Escudier and Aditya Tyagi discuss how social media listening is used in clinical research, how it supports established evidence-generation methods, and how it can become a credible, structured input for drug development.